Skip to content

Assessment of RE symptoms in Japan and evaluation of treatment satisfaction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021993
Enrollment
2000
Registered
2016-08-18
Start date
2016-04-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflux esophagitis

Interventions

None listed

Sponsors

AstraZeneca K.K. Medical
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who give informed consent through the internet. 2.Patients who are 20 years of age and older at the time of receiving IC. 3.Patients who are diagnosed as a RE by doctors 4. Patients who are administered one or more drugs prescribed by doctors among the followings used to treat RE for at least more than four weeks to make heartburn and acid reflux disappear or to achieve lasting remission.

Exclusion criteria

Exclusion criteria: Subjects suspected of poor capability follow instructions of the survey.

Design outcomes

Primary

MeasureTime frame
The appropriate multivariate regression model is developed by using the treatment satisfaction questionnaire (TSQ) score as the response variable, by using the baseline characteristics and the degree (severity or frequency) of RE related subjective symptoms as the explanatory variables. Furthermore, the coefficient of determination and the standardized regression coefficient of that model are calculated.

Secondary

MeasureTime frame
The appropriate multivariate regression model is developed by using the satisfaction score which is TSQ's sub-category as the response variable, by using the other sub-categories, the baseline characteristics and the degree of RE related subjective symptoms as the explanatory variables. Furthermore, the coefficient of determination and the standardized regression coefficient of that model are calculated.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026